AKT1 and non-small cell lung carcinoma: We found that lumbrokinase treatment also down-regulated the expression of BPTF at the mRNA and protein levels (Figure 2D,E), suggesting that, most likely, lumbrokinase inactivates PI3K/AKT and MAPK/ErK signaling pathways in NSCLC cells by targeting BPTF/VEGF pathway.